XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue $ 0 $ 705
Operating expenses:    
Research and development 59,471 51,999
General and administrative 30,265 26,743
In-process research and development 520,915 0
Impairment of intangible assets 0 8,468
Total operating expenses 610,651 87,210
Other operating income 1,001 14,416
Operating loss (609,650) (72,089)
Other expense, net (5,278) (6,693)
Loss before income tax (614,928) (78,782)
Net loss $ (614,928) $ (78,782)
Net loss per share:    
Basic (in dollars per share) $ (0.99) $ (0.41)
Diluted (in dollars per share) $ (0.99) $ (0.41)
Weighted average common shares outstanding:    
Basic (in shares) 619,646,180 193,336,063
Diluted (in shares) 619,646,180 193,336,063
Other comprehensive (loss) income:    
Foreign currency translation adjustments $ (172) $ 304
Reclassification of cumulative currency translation gain to other expense, net (419) 0
Unrealized gain on short-term investments 36 0
Comprehensive loss $ (615,483) $ (78,478)